abstract |
The present invention relates to a benzimidazole compound useful in the treatment of protein kinase-related disorders. It also relates to compounds useful in the treatment or prevention of one or more cancers, symptoms of transplant rejection. In addition, methods of modulating the activity of protein kinases such as CDK4 and/or CDK6 by the compounds provided herein are also contemplated. |